HCC diagnosis was confirmed in TACE patients by needle biopsy (11.6%) or using two imaging techniques in conjunction with a serum level of α-fetoprotein (AFP) higher than 400 ng/mL (88.4%). This evidence concerns the gene AFP and hepatocellular carcinoma.